An Observational Study to Assess Real-World Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in China
Clinical trial NCT06421740 · COMPLETED
Trial details
- NCT number
- NCT06421740
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-06-07
- Primary completion
- 2026-05-25
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.